Gary Richter
Atlanta, GANPI 1639178866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 50.1% of the total.
Across 227 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$618
- Johnson & Johnson$350
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$222
- Nestle Healthcare Nutrition Inc.$139
- Ferring Pharmaceuticals Inc.$95
- plus $861 from 18 others
Across 13 payments — averaging $3165.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$17K
- Bristol Myers Squibb$17K
- Ironwood Pharmaceuticals, Inc$7K
What the payments were for
- Consulting fees$180%
- Food & beverage$4,46798%
- Gifts$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 110 | $2,290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $618 |
| Johnson & Johnson | 19 | $350 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $222 |
| Nestle Healthcare Nutrition Inc. | 8 | $139 |
| Ferring Pharmaceuticals Inc. | 6 | $95 |
| Bristol Myers Squibb | 5 | $93 |
| Madrigal Pharmaceuticals | 3 | $90 |
| Braintree Laboratories, Inc. | 2 | $89 |
| Gilead | 4 | $85 |
| Ironwood Pharmaceuticals, Inc | 5 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Novo Nordisk | 2 | $40 |
| Exact Sciences | 2 | $38 |
| Boston Scientific | 1 | $30 |
| Pfizer | 2 | $28 |
| Redhill Biopharma Inc. | 2 | $27 |
| Alfasigma USA, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $17 |
| Intra-sana Laboratories | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 115 | $96,260 |
| CreonLipase/Protease/Amylase | 15 | $36,060 |
| Mesalamine | 32 | $18,667 |
| Dexlansoprazole DrDexlansoprazole | 43 | $12,779 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 181 | $11,618 |
| AprisoMesalamine | 13 | $7,584 |
| Sucralfate | 37 | $5,780 |
| Famotidine | 86 | $1,313 |
| Esomeprazole Magnesium | 32 | $932 |
| Pantoprazole Sodium | 54 | $821 |
| Dicyclomine Hcl | 18 | $635 |
| Omeprazole | 42 | $603 |
| Ondansetron OdtOndansetron | 28 | $491 |
| Hydrocortisone | 22 | $360 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $2,290 | $132,321130 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCApriso | $222 | $7,58413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.